3 results
Approved WMOPending
To study nocturnal FFA rhythm with or without *-blockers in insulin resistant subjects and healthy controls.
Approved WMOPending
The objective of this study is to evaluate the clinical efficacy, biological effects and safety of anifrolumab treatment in pSS.
Approved WMOCompleted
The primary objective is to determine the clinical response of propranolol monotherapy in patients with angiosarcoma. The secondary endpoint is to assess the pathologic response of propranolol monotherapy in patients with angiosarcoma.